If you have been reading about aggregation and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-07-15. Numbers and descriptions here follow the published literature rather than marketing material.
Reconstitution is often performed with sterile water, buffer, or a water-miscible organic solvent, depending on solubility. The solvent should be added gently along the vial wall, and the solution mixed by gentle swirling rather than vigorous vortexing, which can cause foaming and surface denaturation. Some sequences require a small amount of base or acid to dissolve, followed by pH adjustment. Preparing a concentrated stock solution can simplify later dilution, but the stock itself may have limited stability. Records of solvent, concentration, and date support reproducibility.
After reconstitution, dividing the solution into single-use aliquots limits multiple warming and cooling events and reduces contamination risk. Low-binding polypropylene tubes are often preferred because peptides can adsorb to glass or untreated plastic surfaces. Filling headspace with nitrogen or argon can slow oxidation, and amber or foil-wrapped containers reduce photodegradation. Each aliquot should be labeled with peptide identity, concentration, date, and storage conditions. Frozen aliquots should be thawed quickly and kept on ice until use.
When a peptide arrives, the vial should be inspected for damage, and its label, lot number, and accompanying analytical data should be recorded. Cold vials should equilibrate to room temperature before opening to prevent condensation on the powder. Moisture uptake can reduce stability and complicate accurate weighing or reconstitution. Inventory systems that track date, quantity, and storage location help prevent unnecessary temperature cycling. Personnel should follow institutional or manufacturer instructions for any specific peptide.
Receiving a peptide begins with recording its identity, lot number, quantity, and arrival condition. Dry material is often kept in sealed containers with desiccant and an inert headspace to limit moisture and oxygen. Containers should be compatible with the peptide and solvent; some peptides adsorb to certain plastics or glass. Labels should include date, concentration, solvent, and storage location. A centralized inventory with temperature logs helps prevent loss and mix-ups.
Reconstitution involves adding a solvent to dry peptide, often water or a buffered solution. The chosen liquid should match the peptide's solubility and intended assay, and it should be free of contaminants. Gentle mixing or inversion reduces foaming and shear, which can damage some peptides. If the peptide does not dissolve readily, adjusting pH or using a small amount of organic co-solvent may help. The final solution is typically clarified before use in analytical or laboratory procedures.
After reconstitution, solutions are usually divided into single-use aliquots to limit repeated handling. Each aliquot is stored at a temperature appropriate for the peptide, with -20 °C or -80 °C common for longer-term laboratory storage. Freeze-thaw cycles are minimized because they can cause aggregation, precipitation, or loss of activity. Temperature monitoring and documented storage conditions support reproducibility across experiments. When a peptide is removed from storage, it is typically allowed to equilibrate before opening to reduce condensation.
| Property | Value | Notes |
|---|---|---|
| Container material | Type I borosilicate glass or polypropylene | Low peptide adsorption; avoid untreated polystyrene for dilute solutions. |
| Headspace gas | Nitrogen or argon | Inert gas reduces oxidation for methionine- or cysteine-containing peptides. |
| Light exposure | Amber vial or foil wrap | Limits photodegradation of tryptophan, tyrosine, and phenylalanine residues. |
| Reconstitution solvent | Water, buffer, or water-miscible organic solvent | Choice depends on sequence charge and hydrophobicity; use highest available purity. |
| Aliquot size | Single-use portions | Minimizes warming and cooling cycles and cross-contamination between uses. |
Peptides are short chains of amino acids whose physical and chemical stability depends on sequence, length, and conformation. The amide backbone can hydrolyze under acidic or basic conditions, while side chains such as methionine, cysteine, and tryptophan are prone to oxidation. Aggregation may occur when hydrophobic regions associate, especially near surfaces or at high concentration. Because these pathways differ among peptides, no single storage condition applies to all sequences. Stability studies therefore examine each peptide under defined temperature, pH, and humidity ranges.
Temperature is a primary variable because most degradation reactions slow as thermal energy decreases. Lyophilized powders are commonly held at -20 °C for routine work and at -80 °C for longer archival periods, though exact recommendations depend on the peptide. Solutions are less stable than dry powders in many cases, and repeated freeze-thaw cycles can promote aggregation or precipitation. Inert atmospheres, such as argon or nitrogen, can limit oxidation for oxygen-sensitive sequences. Desiccants reduce water activity, which lowers hydrolysis rates during storage.
Light exposure can damage aromatic residues and certain labels, so amber vials or opaque containers are often used. pH control matters in solution, as extreme acidity or alkalinity accelerates backbone cleavage; buffers may also introduce ions that affect solubility. Microbial growth is a concern for aqueous preparations that lack preservatives, though many research peptides are handled in sterile or low-bioburden conditions. Container materials can adsorb peptides, particularly hydrophobic or positively charged sequences, reducing recovery. These factors interact, meaning storage decisions balance chemical stability, physical state, and intended use.
Handling begins when a peptide container is opened. Hygroscopic solids can absorb atmospheric water rapidly, so bench work should be brief and containers resealed with fresh desiccant. Weighing or transferring should occur in a low-humidity environment where possible. Static electricity may cause fine powders to cling to surfaces, leading to inaccurate mass measurements. Tools such as antistatic devices or grounded workstations reduce that problem. Good laboratory practice also includes labeling date, lot, and storage condition after each opening.
Reconstitution introduces new variables. The solvent should match the peptide's solubility profile, and water or buffer quality matters because trace metals and microbes can alter results. Adding solvent gently down the vial wall minimizes foaming, which can denature some sequences. Mixing by gentle inversion or swirling is usually preferred over vigorous vortexing. If a peptide does not dissolve readily, adjusting pH or using a small amount of organic co-solvent may help, but such steps can also affect stability and should be documented.
Peptides are short chains of amino acids linked by amide bonds. Their stability depends on sequence, length, and the chemical environment. Common degradation routes include hydrolysis of the peptide backbone, oxidation of methionine or cysteine residues, deamidation of asparagine or glutamine, and aggregation through hydrophobic or electrostatic interactions. These processes can alter mass, charge, or biological activity, so storage conditions aim to slow them. The relative importance of each route varies widely among peptides.
Water is a central factor in peptide degradation because it enables hydrolysis and mobilizes reactive species. Lyophilized or dry powders typically remain stable for longer than solutions when kept cool and dry. Oxygen can drive oxidation, particularly for sulfur-containing residues, while light can catalyze side-chain damage. Buffer choice and pH influence charge state and can accelerate or slow deamidation and aggregation. Freeze-thaw cycles may concentrate solutes or promote ice-induced aggregation, so minimizing such cycles is a common handling goal.
With both P-selectin and ICAM-1 on the substrate, cells attached and rolled, but the presence of ICAM-1 had no effect. However, if a neutrophil chemoattractant was added to the flow stream, it activated GPCR signaling, actin polymerization, and integrin-dependent firm adhesion to ICAM-1. Springer integrated these findings into the “three step paradigm” of leukocyte extravasation (diapedesis), which has become the standard framework for understanding leukocyte trafficking in inflammation. The laboratory of Eugene Butcher, including postdoctoral fellow Uli von Andrian, was working on emigration of leukocytes in vivo at the same time, and discovered that antibody to leukocyte integrins inhibited firm adhesion, but not rolling adhesion, to postcapillary venules at sites of inflammation. Butcher and Springer received the 2004 Crafoord Prize for this work. Springer's paradigm that integrins on leukocytes bind to counter-receptors with Ig-like domains on endothelium was later extended by others to integrin α4β1 binding to vascular cell adhesion molecule-1 (VCAM-1), which is inducible by inflammatory mediators on endothelium, and α4β7 binding to mucosal addressin cell adhesion molecule-1 (MAdCAM-1), which is constitutively expressed on mucosal endothelium. At the time that Springer described the three step model, no chemoattractants for peripheral blood lymphocytes that could stimulate emigration were known. Their existence was implied by the ability of pertussis toxin, which modifies the G protein Gαi subunit, to cause lymphocytosis in patients with whooping cough.
The intra-articular portion is made of longitudinal fibers pretwisted at a 90 degree angle. This section is designed to resist fatigue and promote tissue ingrowth. Leeds Keio ligaments consist of a polyester mesh structure. It seeks to mimic the mechanical properties of the native ACL. The porous nature of the ligament can promote tissue ingrowth which has been shown to improve mechanical properties. The PGA Dacron artificial graft consists of 75% braided biodegradable polyglycolic acid and 25% permanent Dacron thread. The Kennedy LAD artificial ligament is made of polypropylene ribbons. It is designed to promote tissue ingrowth and the progressive transfer of load onto the new ligament.
Biodiversity informatics deals with the collection and analysis of biodiversity data, such as taxonomic databases, or microbiome data. Examples of such analyses include phylogenetics, niche modelling, species richness mapping, DNA barcoding, or species identification tools. A growing area is also macro-ecology, i.e. the study of how biodiversity is connected to ecology and human impact, such as climate change. The enormous number of published literature makes it virtually impossible for individuals to read every paper, resulting in disjointed sub-fields of research. Literature analysis aims to employ computational and statistical linguistics to mine this growing library of text resources. For example: Abbreviation recognition – identify the long-form and abbreviation of biological terms Named-entity recognition – recognizing biological terms such as gene names Protein–protein interaction – identify which proteins interact with which proteins from text The area of research draws from statistics and computational linguistics.
Sources: en.wikipedia.org
== Treatment == By definition, TIAs are transient, self-resolving, and do not cause permanent impairment. However, they are associated with an increased risk of subsequent ischemic strokes, which can be permanently disabling. Therefore, management centers on the prevention of future ischemic strokes and addressing any modifiable risk factors. The optimal regimen depends on the underlying cause of the TIA.
During his life in retirement, from 1959 up to his death in 1973, Tolkien received steadily increasing public attention and literary fame. In 1961 his friend C. S. Lewis even nominated him for the Nobel Prize in Literature. The sales of his books were so profitable that he regretted that he had not chosen early retirement. In a letter in 1972 he deplored having become a cult figure, but admitted that "even the nose of a very modest idol ... cannot remain entirely untickled by the sweet smell of incense!" Fan attention became so intense that Tolkien had to take his phone number out of the public directory; eventually he and Edith moved to Bournemouth, which was then a seaside resort patronized by the British upper middle class. Tolkien's status as a best-selling author gave them easy entry into polite society, but Tolkien deeply missed the company of his fellow Inklings. Edith, however, was overjoyed to step into the role of a society hostess, which had been the reason that Tolkien selected Bournemouth in the first place. The genuine and deep affection between Ronald and Edith was demonstrated by their care about the other's health, in details like wrapping presents, in the generous way he gave up his life at Oxford so she could retire to Bournemouth, and in her pride in his becoming a famous author. They were also united by love for their children and grandchildren. In his retirement Tolkien was a consultant and translator for The Jerusalem Bible, published in 1966.
In contrast, Slavic settlements in southern Ukraine started to appear relatively early during Cuman rule, with the earliest, such as Oleshia, dating back to the 11th century. Early "Proto-Cossack" groups are generally reported to have come into existence within what is now Ukraine prior to the 13th century as the influence of Cumans grew weaker, although some have ascribed their origins to as early as the mid-8th century. Some historians suggest that the Cossack people were descended from East Slavs, Turks, Tatars, Circassians and others who settled or passed through the vast regions. There are archeological indications, according to Turkologists, that Cossacks are descendants of the native Cumans of Ukraine, who had lived there long before the Mongol invasion. Other theories expand upon that assertion to suggest that the first Cossacks were of Turkic origin. For example, according to Serhii Plokhy, the first Cossacks were of Turkic rather than Slavic stock. Christoph Baumer states that Cossack predecessors from the thirteenth century onward were mainly of Turkic stock, but from the sixteenth century the Cossacks were increasingly joined by Slavs such as Russians and Poles, Baltic Lithuanians and people from today's Ukraine, thus becoming a Slav-Tatar ethnic hybrid. The theory is also reflected in the Constitution of Pylyp Orlyk of 1710 and the Hrabianka Chronicle, which claims Khazar origins for the Cossacks. The Khazar origin myth became popular during the rule of Ivan Mazepa, a reaction against the Polish myth of Sarmatism.
Sources: en.wikipedia.org
=== Yum! Brands subsidiary === PepsiCo spun out Taco Bell and its other restaurant chains in late 1997 in Tricon Global Restaurants. With the purchase of Yorkshire Global Restaurants, the owners of A&W and Long John Silver's chains, Tricon changed its name to Yum! Brands on May 16, 2002. In March 2005, the Coalition of Immokalee Workers (CIW) won a landmark victory in its national boycott of Taco Bell for human rights. Taco Bell agreed to meet all the coalition's demands to improve wage and working conditions for Florida tomato pickers in its supply chain. After four years of boycott, Taco Bell and Yum! Brands agreed to make an agreement called the CIW-Yum agreement with representatives of CIW at Yum! Brands headquarters.
In 2024, Marvel Studios introduced the "Marvel Animation" and "Marvel Television" banners for their animated and live-action series, respectively. This was done, along with the previously established Marvel Spotlight banner, to indicate to audiences that they did not have to watch all of the studio's projects to understand the overall story and could choose which storylines and characters to follow. In July 2025, Feige said the studio reduced the budgets of its 2024 and 2025 films to be a third lower than those for 2022 and 2023.
Caesium-137, with a half-life of 30.04 years, is one of the two principal medium-lived fission products, along with 90Sr, which are responsible for most of the radioactivity of spent nuclear fuel from several years up to several hundred years after use. It constitutes most of the radioactivity still left from the Chernobyl accident and is a major health concern for decontaminating land near the Fukushima nuclear power plant. 137Cs beta decays to barium-137m (a short-lived nuclear isomer), which in de-excitation to its stable ground state barium-137, usually emits a gamma ray. This process is responsible for all the gamma emission from caesium-137. 137Cs has a very low rate of neutron capture and cannot yet be feasibly disposed of in this way unless advances in neutron beam collimation (not otherwise achievable by magnetic fields), uniquely available only from within muon catalyzed fusion experiments (not in the other forms of Accelerator Transmutation of Nuclear Waste) enables production of neutrons at high enough intensity to offset and overcome these low capture rates; until then, therefore, 137Cs must simply be allowed to decay. 137Cs has been used as a tracer in hydrologic studies, analogous to the use of 3H.
Sources: en.wikipedia.org
Dividing a stock into single-use portions usually reduces multiple thawing and refreezing events and lowers contamination risk. It also allows a needed amount to be removed without warming the entire supply.
Peptides can adsorb to some plastics and glass, especially at low concentrations, which reduces the measured amount in solution. Low-binding polypropylene tubes limit this loss and improve reproducibility.
Thawing on ice or in a cold water bath is generally preferred over rapid heating, which can accelerate degradation. Once thawed, the aliquot should be kept cold and used promptly rather than refrozen.
Dry peptides are generally kept in sealed, desiccated containers at low temperature, often -20 °C or colder. Protection from light, moisture, and oxygen helps slow degradation. The exact condition depends on the peptide sequence and supplier guidance.